Literature DB >> 18765640

The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathways.

Anaïs Perilhou1, Cécile Tourrel-Cuzin, Ilham Kharroubi, Carole Henique, Véronique Fauveau, Tadahiro Kitamura, Christophe Magnan, Catherine Postic, Carina Prip-Buus, Mireille Vasseur-Cognet.   

Abstract

COUP-TFII has an important role in regulating metabolism in vivo. We showed this previously by deleting COUP-TFII from pancreatic beta cells in heterozygous mutant mice, which led to abnormal insulin secretion. Here, we report that COUP-TFII expression is reduced in the pancreas and liver of mice refed with a carbohydrate-rich diet and in the pancreas and liver of hyperinsulinemic and hyperglycemic mice. In pancreatic beta cells, COUP-TFII gene expression is repressed by secreted insulin in response to glucose through Foxo1 signaling. Ex vivo COUP-TFII reduces insulin production and secretion. Our results suggest that beta cell insulin secretion is under the control of an autocrine positive feedback loop by alleviating COUP-TFII repression. In hepatocytes, both insulin, through Foxo1, and high glucose concentrations repress COUP-TFII expression. We demonstrate that this negative glucose effect involves ChREBP expression. We propose that COUP-TFII acts in a coordinate fashion to control insulin secretion and glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765640      PMCID: PMC2573225          DOI: 10.1128/MCB.02211-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

Authors:  Renaud Dentin; Fadila Benhamed; Isabelle Hainault; Véronique Fauveau; Fabienne Foufelle; Jason R B Dyck; Jean Girard; Catherine Postic
Journal:  Diabetes       Date:  2006-08       Impact factor: 9.461

2.  Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell.

Authors:  Sara C Martinez; Corentin Cras-Méneur; Ernesto Bernal-Mizrachi; M Alan Permutt
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

3.  Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.

Authors:  Renaud Dentin; Fadila Benhamed; Jean-Paul Pégorier; Fabienne Foufelle; Benoit Viollet; Sophie Vaulont; Jean Girard; Catherine Postic
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

4.  Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation.

Authors:  Kim Ravnskjaer; Michael Boergesen; Louise T Dalgaard; Susanne Mandrup
Journal:  J Mol Endocrinol       Date:  2006-04       Impact factor: 5.098

5.  Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.

Authors:  Katsumi Iizuka; Bonnie Miller; Kosaku Uyeda
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-05-16       Impact factor: 4.310

6.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis.

Authors:  Katsumi Iizuka; Richard K Bruick; Guosheng Liang; Jay D Horton; Kosaku Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 7.  Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism.

Authors:  Massimo U De Martino; Salvatore Alesci; George P Chrousos; Tomoshige Kino
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

8.  FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.

Authors:  Wenwei Zhang; Sandip Patil; Balwant Chauhan; Shaodong Guo; David R Powell; Jamie Le; Angelos Klotsas; Ryan Matika; Xiangshan Xiao; Roberta Franks; Kim A Heidenreich; Mini P Sajan; Robert V Farese; Donna Beer Stolz; Patrick Tso; Seung-Hoi Koo; Marc Montminy; Terry G Unterman
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

9.  Peroxisome proliferator-activated receptor gamma coactivator-1alpha, as a transcription amplifier, is not essential for basal and hormone-induced phosphoenolpyruvate carboxykinase gene expression.

Authors:  Birger Herzog; Robert K Hall; Xiaohui L Wang; Mary Waltner-Law; Daryl K Granner
Journal:  Mol Endocrinol       Date:  2004-04

10.  Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing.

Authors:  Gabriela Da Silva Xavier; Qingwen Qian; Peter J Cullen; Guy A Rutter
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

View more
  17 in total

1.  CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability.

Authors:  Lilia G Noriega; Jérôme N Feige; Carles Canto; Hiroyasu Yamamoto; Jiujiu Yu; Mark A Herman; Chikage Mataki; Barbara B Kahn; Johan Auwerx
Journal:  EMBO Rep       Date:  2011-09-30       Impact factor: 8.807

Review 2.  Coup d'Etat: an orphan takes control.

Authors:  Fu-Jung Lin; Jun Qin; Ke Tang; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Endocr Rev       Date:  2011-01-21       Impact factor: 19.871

Review 3.  COUP-TFII revisited: Its role in metabolic gene regulation.

Authors:  Usman M Ashraf; Edwin R Sanchez; Sivarajan Kumarasamy
Journal:  Steroids       Date:  2018-11-24       Impact factor: 2.668

4.  The nutritional induction of COUP-TFII gene expression in ventromedial hypothalamic neurons is mediated by the melanocortin pathway.

Authors:  Lina Sabra-Makke; Cécile Tourrel-Cuzin; Raphaël G P Denis; Marthe Moldes; Jean-Paul Pégorier; Serge Luquet; Mireille Vasseur-Cognet; Pascale Bossard
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

5.  Hypothalamic ventromedial COUP-TFII protects against hypoglycemia-associated autonomic failure.

Authors:  Lina Sabra-Makke; Micol Maritan; Julien Planchais; Marie Boutant; Jean-Paul Pégorier; Patrick C Even; Mireille Vasseur-Cognet; Pascale Bossard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

6.  The expression of Apoc3 mRNA is regulated by HNF4α and COUP-TFII, but not acute retinoid treatments, in primary rat hepatocytes and hepatoma cells.

Authors:  Meredith Howell; Rui Li; Rui Zhang; Yang Li; Wei Chen; Guoxun Chen
Journal:  Mol Cell Biochem       Date:  2013-11-15       Impact factor: 3.396

Review 7.  Multiple roles of COUP-TFII in cancer initiation and progression.

Authors:  Lacey M Litchfield; Carolyn M Klinge
Journal:  J Mol Endocrinol       Date:  2012-10-10       Impact factor: 5.098

8.  SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII.

Authors:  Wulin Aerbajinai; Jianqiong Zhu; Chutima Kumkhaek; Kyung Chin; Griffin P Rodgers
Journal:  Blood       Date:  2009-04-28       Impact factor: 22.113

9.  Seven-Up Is a Novel Regulator of Insulin Signaling.

Authors:  Laura Palanker Musselman; Jill L Fink; Ezekiel J Maier; Jared A Gatto; Michael R Brent; Thomas J Baranski
Journal:  Genetics       Date:  2018-02-27       Impact factor: 4.562

10.  Rare variants in NR2F2 cause congenital heart defects in humans.

Authors:  Saeed Al Turki; Ashok K Manickaraj; Catherine L Mercer; Sebastian S Gerety; Marc-Phillip Hitz; Sarah Lindsay; Lisa C A D'Alessandro; G Jawahar Swaminathan; Jamie Bentham; Anne-Karin Arndt; Jacoba Louw; Jacoba Low; Jeroen Breckpot; Marc Gewillig; Bernard Thienpont; Hashim Abdul-Khaliq; Christine Harnack; Kirstin Hoff; Hans-Heiner Kramer; Stephan Schubert; Reiner Siebert; Okan Toka; Catherine Cosgrove; Hugh Watkins; Anneke M Lucassen; Ita M O'Kelly; Anthony P Salmon; Frances A Bu'lock; Javier Granados-Riveron; Kerry Setchfield; Chris Thornborough; J David Brook; Barbara Mulder; Sabine Klaassen; Shoumo Bhattacharya; Koen Devriendt; David F Fitzpatrick; David I Wilson; Seema Mital; Matthew E Hurles
Journal:  Am J Hum Genet       Date:  2014-04-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.